Literature DB >> 8770575

Cerebrospinal fluid drainage for syringomyelia.

B Williams1, S Sgouros, E Nenji.   

Abstract

Twenty-eight years of experience with syringomyelia of various causes in the syringomyelia clinic at the Midland Centre for Neurosurgery and Neurology has provided a database of 723 patients, mostly adults, with either hindbrain herniation, syringomyelia or both. Treatment of syringomyelia by drainage has never been the optimum primary treatment on the basis that the cavity is usually secondary to some other disturbance of the cerebrospinal fluid pathways. Over this period 73 patients had either syrinx drainage (56 syringopleural, 14 syringo-subarachnoid shunts) or other procedure such as myelotomy and cord transection. Ten years after operation only 53.5% and 50% of these two groups respectively continued to remain clinically stable. A complication rate of 15.7% included fatal haemorrhage, infection and displacement of drains. At second operation or necropsy at least 5% of shunts were found to be blocked. All the shunts were inserted without a valve and the lowering of the intrasyrinx pressure has therefore been energetic when the lower end of the drainage tube has been taken to the pleural or peritoneal cavities. This produced collapse of the cord cavities around the tip of the drainage tube and increased the likelihood of blockage. If the mechanisms which were responsible for the syringomyelia were still operative then recurrence was likely to occur alongside the drainage tube leaving the tube immured in the wall of the syrinx cavity. When hydrocephalus was present, in addition treatment of the hydrocephalus by a valved shunt to the peritoneum or to the right atrium was often effective in improving the syringomyelia. This treatment has also been used in patients without hydrocephalus. The mechanisms of improvement were unclear but this treatment stratagem has nevertheless been employed in 45 cases. In 30 out of these 45 cases the drainage of cerebrospinal fluid from outside the syrinx cavities seemed to be worthwhile; 10 patients suffered some form of complication, most of which were reversible; 8 patients were worse following surgery. It is concluded that both drainage of the syringomyelia cavity and also extra-syrinx drainage may have a place in the management of difficult syringomyelia problems although the primary treatment should be to establish the patency of CSF pathways in both hindbrain-related and non-hindbrain-related cases.

Entities:  

Mesh:

Year:  1995        PMID: 8770575     DOI: 10.1055/s-2008-1066259

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  6 in total

Review 1.  Pathogenesis of syringomyelia associated with Chiari type 1 malformation: review of evidences and proposal of a new hypothesis.

Authors:  Izumi Koyanagi; Kiyohiro Houkin
Journal:  Neurosurg Rev       Date:  2010-06-08       Impact factor: 3.042

2.  Pathophysiology of persistent syringomyelia after decompressive craniocervical surgery. Clinical article.

Authors:  John D Heiss; Giancarlo Suffredini; René Smith; Hetty L DeVroom; Nicholas J Patronas; John A Butman; Francine Thomas; Edward H Oldfield
Journal:  J Neurosurg Spine       Date:  2010-12

3.  A new surgical method for treating syringomyelia secondary to arachnoiditis following cervical spine surgery: the syringo-cisterna magna shunt.

Authors:  Pyung Goo Cho; Sung Hyun Noh; Sang Hyun Kim
Journal:  Eur Spine J       Date:  2022-02-02       Impact factor: 3.134

4.  New surgical approach for late complications from spinal cord injury.

Authors:  Antonio J Reis
Journal:  BMC Surg       Date:  2006-10-23       Impact factor: 2.102

5.  Intracranial hypotension after syringopleural shunting in posttraumatic syringomyelia: Case report and review of the literature.

Authors:  Johanne C Summers; Yagnesh Vellore; Patrick C H Chan; Jeffrey V Rosenfeld
Journal:  Asian J Neurosurg       Date:  2015 Apr-Jun

6.  Novelty in Impact of Neurorehabilitation in a Classic Case of Syringomyelia.

Authors:  Sanika P Gade; Pallavi Harjpal; Rakesh K Kovela
Journal:  Cureus       Date:  2022-09-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.